A national quality registry for spondyloarthritis in daily practice in the Netherlands

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON20216

Enrollment

1000

Registered

2017-10-02

Start date

2016-05-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spondyloartritis, ankylosing spondylitis, psoriatic arthritis, reactive arthritis, spondyloarthritis associated with inflammatory bowel disease, and undifferentiated spondyloarthritis

Interventions

None, daily care. Through MIJNREUMACENTRUM, a web-based patient medical file and at the same time a quality management system, patient outcome and pharmacovigilance data are prospectively gathered fro

Eligibility

Inclusion criteria

Inclusion criteria: Any patients with a diagnosis of spondyloarthritis according to his/her treating rheumatologist can be included

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Quality of life	—

Secondary

Measure	Time frame
Disease activity state, work productivity	—

Contacts

Public ContactA. Tubergen, van

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)